Associate Professor
Department of Pediatrics and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health
Dr. Christian Capitini is the Jean R. Finley Professor of Pediatric Hematology and Oncology and Associate Professor of Pediatrics recently chosen to be Chief of the Division of Hematology, Oncology and Bone Marrow Transplant at the University of Wisconsin (UW)-School of Medicine and Public Health. He also serves as Co-Leader of the Developmental Therapeutics Program at the UW Health - Carbone Cancer Center. Dr. Capitini leads an NIH-supported laboratory focusing on development of cell-based therapies for the treatment of pediatric tumors and for complications of bone marrow transplant. He has published over 60 peer-reviewed papers and filed 7 patents.
In the clinic, Dr. Capitini is a Principal Investigator (PI) for an investigator-initiated clinical trial testing an experimental stem cell transplant for high risk childhood cancers. He was also site PI for the first multicenter CAR T cell trial from a “Pediatric Cancer Dream Team” through Stand up to Cancer and St. Baldrick’s Foundation, which lead to the FDA approval of tisagenlecleucel (Kymriah) for relapsed or refractory B cell leukemia in children. Presently he is a site PI for multiple Kymriah trials for the upfront treatment of high-risk B cell leukemia and for a long term followup study. He is also a site PI for a multicenter CAR T cell trial for treating neuroblastoma and osteosarcoma through the Pediatric Cancer Immunotherapy Trials Network (CITN).
Dr. Capitini presently serves as an At-Large Director for the Society for Immunotherapy of Cancer, on the Executive Committee for the Madison chapter of the Leukemia and Lymphoma Society and on the Executive Committee for the Pediatric Real World CAR T Consortium.
